Tenderwize
Retour à la recherche

Dynamic Purchasing System for Pharmaceutical Products

Intercent-ER — Agenzia regionale per lo sviluppo dei mercati telematici·Bologna, Italy·EUR 15000M·Deadline Feb 24, 2028 · 552 days left·Restricted·Supplies·DPS
Inscrivez-vous pour sauvegarderOpen documents
High value
Titre original de l'avis

Italy – Pharmaceutical products – Istituzione del Sistema Dinamico di Acquisizione per la fornitura di Beni Farmaceutici. Finalizzato alla partecipazione di Appalti specifici per la stipula di Convenzioni/Accordi quadro. Il SDA potrà.

60/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesDPSOpen
Pourquoi ce score ?

Opportunité

60 / 100

Complexité

40 / 100

Facteurs de risque

Structured data indicates DPS duration of 132 months and EU-funded, but XML notice shows 96 months validity and no EU f...

No procurement documents were analyzed; eligibility, award criteria, and detailed requirements are unknown.

Restricted procedure — pre-qualification required

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • EUR 15000M estimated value
  • Dynamic Purchasing System (DPS)
  • Supplies contract
  • 1 lot
  • Duration 132 MONTH
  • Establishment of a Dynamic Purchasing System for pharmaceutical products
  • Specific contracts to be awarded via invitation to qualified suppliers
Afficher le résumé complet

Establishment of a Dynamic Purchasing System (DPS) for pharmaceutical products, usable by Intercent-ER and regional health authorities. Single lot (LOT-0000) with estimated value of €15 billion. The DPS has a duration of 132 months (per structured data) but XML notice indicates 96 months validity. Submission deadline is 2028-02-24. Inconsistencies exist in duration and EU funding flags. Procedure is restricted; language is Italian only.

Risques

Structured data indicates DPS duration of 132 months and EU-funded, but XML notice shows 96 months validity and no EU f...

No procurement documents were analyzed; eligibility, award criteria, and detailed requirements are unknown.

Restricted procedure — pre-qualification required

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Admission to DPS via electronic request throughout its validity
  • Compliance with requirements specified in individual invitations

Administrative

  • Electronic submission only via the provided platform

Critères d'attribution

Lot 1

Award criteria not specified at DPS level; will be defined in specific contracts.

Acheteur

Localisation

Bologna, ITA

Profil acheteur

Ouvrir le profil

Identifiant

0000246017

Activité

General public services

Lots (1)

LOT-0000

Dynamic Purchasing System for Pharmaceutical Products

Establishment of a DPS for the supply of pharmaceutical products. Specific contracts will be awarded via invitations, with detailed requirements per contract.

SuppliesDPSEU fundedElectronic submission

EUR 15B

Valeur estimée

Localisation

ITH55, Italy

Durée

132 MONTH

Catégorie

Pharmaceutical products

Critères d'attribution

Award criteria not specified at DPS level; will be defined in specific contracts.

Date limite

Deadline Feb 24, 2028

Détails de la procédure

Date de publication
24 Feb 2025
Langues
Italian

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
125860-2025

Documents (2)

Document de consultation 1Portail de soumission 1

Appels d'offres similaires

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

France – Pharmaceutical products – 26-10 : ACCORD-CADRE DE FOURNITURE DE MÉDICAMENTS 2026

Aug 21

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9